Roche inks $15B ADC pact with Hansoh; Veradermics scores in another baldness study

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 19 Oct, 13:14 UTC

Roche is paying Hansoh $400 million up front in a broad deal involving several ADCs. Elsewhere, another top investor formed a China-focused fund and Ultragenyx sold a second review voucher.

science

Sources

• T2Roche inks $15B ADC pact with Hansoh; Veradermics scores in another baldness studyBioPharma Dive / Healthcare Dive / MedTech Dive19 Oct, 13:14